- For Career: +91-7807836763
- For Business : +91-7807096339
- E-mail : biozenta@gmail.com
Biozenta focuses on technology for development and backward integration for its Oncology Active Pharmaceuticals Ingredients. Biozenta's Oncology API business is boosted by its R&D centre based at UNA, H.P., where a team of dedicated scientists is continuously working to develop cost-effective and non-infringing chemical processes following regulatory guidelines.
Biozenta R&D centre is fully equipped with current safety equipment, including an isolator lab and a separate facility for hydrogenation reactions, as well as unique provisions for low and high-temperature reactions (-80 to +250 C) and cyanation expertise.
Every product undergoes validation steps at the lab, pilot, and plant scales before commercialization to ensure cost-effectiveness and quality attributes for the market and therapeutic domain.
(Biozenta Participating in all Events)
| Events | Dates |
|---|---|
| Ghana | 16-18 May 2023 |
| Belarus (Wegworus) | 23-26 May 2023 |
| Uzbekistan (Wegwors) | 7-9 June 2023 |
| CPHI & PMEC (Shanghai) | 19-21 June 2023 |
| IPHEX Hyderabad | 5-7 July 2023 |
| Nigeria (Wegworus) | 18-20 July 2023 |
| CPHI Bangkok, Thailand | 16-18 August 2023 |
| Iran | 27-29 September 2023 |
| CPHI Worldwide (Barcelona) | 24-26 October 2023 |
| CPHI & PMEC India | 28-30 November 2023 |
Phone
